These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8532546)

  • 1. Critical pathway for administering high-dose chemotherapy followed by peripheral blood stem cell rescue in the outpatient setting.
    Burns JM; Tierney DK; Long GD; Lambert SC; Carr BE
    Oncol Nurs Forum; 1995 Sep; 22(8):1219-24. PubMed ID: 8532546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer care critical pathways: implementing a successful program.
    Patton MD; Katterhagen JG
    Hosp Technol Ser; 1995 Aug; 14(9):1-50. PubMed ID: 10151997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical care for patients receiving autologous hematopoietic stem cell transplantation in the home setting.
    Herrmann RP; Leather M; Leather HL; Leen K
    Oncol Nurs Forum; 1998 Sep; 25(8):1427-32. PubMed ID: 9766296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood progenitor cells: enabling outpatient transplantation.
    McGuire TR; Tarantolo S; Reed E
    Pharmacotherapy; 1998; 18(1 Pt 2):17S-23S. PubMed ID: 9473175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study.
    Genre D; Viens P; Gravis G; Bertucci F; Cowen D; Novakovitch G; Derméche S; Chabannon C; Oziel-Taieb S; Camerlo J; Houvenaeghel G; Jacquemier J; Maraninchi D
    Anticancer Res; 2000; 20(3B):2033-40. PubMed ID: 10928147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient management strategies and transplantation techniques in european stem cell transplantation centers offering breast cancer patients high-dose chemotherapy with peripheral blood stem cell support: a joint report from the EORTC and EBMT.
    Neymark N; Rosti G
    Haematologica; 2000 Jul; 85(7):733-44. PubMed ID: 10897126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplant plus interleukin-2 for breast cancer: review and nursing management.
    Foelber R
    Oncol Nurs Forum; 1998 Apr; 25(3):563-8. PubMed ID: 9568611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical pathway for patients undergoing one-day breast cancer surgery.
    Sladek ML; Swenson KK; Ritz LJ; Schroeder LM
    Clin J Oncol Nurs; 1999 Jul; 3(3):99-106. PubMed ID: 10690040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral blood progenitor cell transplantation for breast cancer: pharmacoeconomic considerations.
    Gilbert CJ
    Pharmacotherapy; 1996; 16(3 Pt 2):101S-108S. PubMed ID: 8726589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer.
    Hohaus S; Wallwiener D; Martin S; Voso MT; Huober J; Fersis N; Bastert G; Haas R
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):7-11; discussion 45-8. PubMed ID: 9578056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
    Brockstein BE; Williams SF
    Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
    deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E
    Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer.
    Brodowicz T; Auerbach L; Zielinski C
    N Engl J Med; 2000 Aug; 343(6):439-40; author reply 440-1. PubMed ID: 10939899
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
    Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF
    Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
    Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
    Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of high-dose chemotherapy and peripheral blood progenitor cell autograft for breast cancer.
    De Rosa L; Lalle M; Pandolfi A; Pescador L
    Bone Marrow Transplant; 2001 May; 27(10):1031-5. PubMed ID: 11438817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer.
    Ford C; Spitzer G; Reilly W; Adkins D
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.